Beijing Beilu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of contrast agents, and central nervous system and hypoglycemic drugs. Its contrast agent products include iohexol injections, iopamidol injections, iodixanol injections, ferric ammonium citrate effervescent granules, and gadopentetate dimeglumine injections. Its central nervous system drugs offer treatment for anxiety disorders. Its hypoglycemic drugs include glimepiride and repaglinide tablets. The company was founded by Dai Xue Wang on September 5, 1992 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company